Lactylation Modification in Cardiometabolic Disorders: Function and Mechanism

Xu Li,Pingdong Cai,Xinyuan Tang,Yingzi Wu,Yue Zhang,Xianglu Rong
DOI: https://doi.org/10.3390/metabo14040217
IF: 4.1
2024-04-12
Metabolites
Abstract:Cardiovascular disease (CVD) is recognized as the primary cause of mortality and morbidity on a global scale, and developing a clear treatment is an important tool for improving it. Cardiometabolic disorder (CMD) is a syndrome resulting from the combination of cardiovascular, endocrine, pro-thrombotic, and inflammatory health hazards. Due to their complex pathological mechanisms, there is a lack of effective diagnostic and treatment methods for cardiac metabolic disorders. Lactylation is a type of post-translational modification (PTM) that plays a regulatory role in various cellular physiological processes by inducing changes in the spatial conformation of proteins. Numerous studies have reported that lactylation modification plays a crucial role in post-translational modifications and is closely related to cardiac metabolic diseases. This article discusses the molecular biology of lactylation modifications and outlines the roles and mechanisms of lactylation modifications in cardiometabolic disorders, offering valuable insights for the diagnosis and treatment of such conditions.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the function and mechanism of lactylation modification in cardiometabolic diseases. Specifically, the paper explores how lactylation, as a post - translational modification (PTM), regulates various cellular physiological processes by changing the spatial conformation of proteins, and this modification is closely related to cardiometabolic diseases (such as ischemic heart disease, heart failure, atherosclerosis, obesity, hypertension and diabetes). The paper aims to provide valuable insights for the diagnosis and treatment of these diseases by summarizing the production, metabolism of lactic acid and its role in the development of cardiometabolic diseases. ### Paper overview - **Research background**: Cardiovascular disease (CVD) is one of the leading causes of death and disability worldwide, and cardiometabolic disease (CMD) is a syndrome of cardiovascular, endocrine, pro - coagulant and inflammatory health hazards. Due to its complex pathological mechanisms, there is currently a lack of effective diagnostic and treatment methods. - **Research purpose**: To explore the function and mechanism of lactylation modification in cardiometabolic diseases and provide new ideas for the diagnosis and treatment of these diseases. - **Research method**: Through literature review and molecular biology analysis, summarize the production, metabolism of lactic acid and its role in cardiometabolic diseases. ### Main content 1. **Cardiometabolic diseases**: - Cardiovascular disease is one of the leading causes of death worldwide, and cardiometabolic diseases include multiple cardiovascular and metabolic risk factors. - Common cardiometabolic diseases include ischemic heart disease, heart failure, atherosclerosis, obesity, diabetes and hypertension. 2. **Lactic acid production, transport and shuttle**: - **Lactic acid production**: Lactic acid is a by - product of glucose metabolism. Under hypoxic conditions, pyruvate is converted into lactic acid by lactate dehydrogenase (LDH). - **Lactic acid transport and shuttle**: Lactic acid is transported in and out of cells through monocarboxylate transporters (MCTs) and participates in signal transduction and the supply of substrates for oxidation and gluconeogenesis. - **Physiological role of lactic acid**: Lactic acid is not only an energy source, but also has the functions of a signal molecule and an immunomodulatory molecule. 3. **Lactylation is a newly discovered post - translational modification**: - **Discovery of lactylation**: In 2019, Zhang et al. first proposed L - lactylation (L - Kla), which is a new PTM. - **Non - enzymatic lactylation**: Gaffney et al. proposed a passive, non - enzymatic lactylation in which lactoyl - glutathione (LGSH) is transferred to lysine residues of proteins. - **"Writer" and "eraser" of lactylation**: The lactylation process depends on lysine acetyltransferase (KAT) - mediated p300 and lactoyl - coenzyme A. p300 has been confirmed as the "writer" of lactylation, while histone deacetylase (HDAC) may act as an "eraser". ### Conclusion The paper systematically summarizes the production, metabolism of lactic acid and its role in cardiometabolic diseases, revealing the important functions and mechanisms of lactylation modification in these diseases. This provides new potential targets and strategies for the diagnosis and treatment of cardiometabolic diseases.